BHVN Competitors & Alternatives

Compare Biohaven Ltd. with similar stocks in the same industry

Biotechnology

BHVN

Main Stock
$13.91
+0.62%
Tradestie Score
42
Market Cap
$1.57B
Analyst Upside
+70.7%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Small molecule CGRP antagonists, Glutamate modulators
Major Customers 5
Physicians Patients Pharmacies Health insurers Distributors
Critical Suppliers 2
Contract manufacturing organizations Clinical research partners
Direct Ecosystem Rivals 3

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
AGIO Agios Pharmaceuticals, Inc.
$30.42
-3.70%
$2.33B - 59 Compare
GLPG Galapagos NV
$27.73
-3.75%
$2.31B 5.1 47 Compare
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock
$2.91
-8.79%
$2.23B - 50 Compare
ADPT Adaptive Biotechnologies Corporation Common Stock
$28.00
-3.58%
$2.22B - 45 Compare
TVTX Travere Therapeutics, Inc. Common Stock
$49.90
-1.48%
$2.21B - 59 Compare
DNLI Denali Therapeutics Inc. Common Stock
$18.33
-2.19%
$2.18B - 51 Compare
MESO Mesoblast Limited American Depositary Shares
$12.47
-6.03%
$2.08B - 33 Compare
SRPT Sarepta Therapeutics,, Inc. Common Stock
$15.14
-5.76%
$2.02B 802.5 41 Compare
NTLA Intellia Therapeutics, Inc
$10.00
+3.09%
$2.01B - 49 Compare
COGT Cogent Biosciences, Inc. Common Stock
$27.45
-3.89%
$1.97B - 39 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)

217 stocks in this industry